Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NABRIVA THERAPEUTICS PLC/ 10-K

Annual Report · 10-K

NABRIVA THERAPEUTICS PLC

Annual Report

Filed Mar 11, 2021Accepted Mar 11, 2021, 11:26 AM ESTCIK 1641640Accession 0001558370-21-002824
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
NBRVOTC · EQUITY · Historical · closed Jul 31, 2023

Recent company filings

  1. 15-12G filingOct 25, 2023
  2. EFFECT filingOct 24, 2023
  3. POS AM filingOct 20, 2023
  4. S-8 POS filingOct 20, 2023
  5. S-8 POS filingOct 20, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗